Predictmedix AI Inc.
PMED
CNSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -21.08% | 31.40% | -49.87% | -52.14% | -67.49% |
| Depreciation & Amortization | -87.32% | -87.80% | -12.26% | -7.77% | -9.55% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.60% | 13.91% | -45.48% | -47.87% | -63.81% |
| Operating Income | 31.60% | -13.91% | 45.48% | 47.87% | 63.81% |
| Income Before Tax | 44.91% | -12.98% | -3.40% | 47.39% | 63.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 44.91% | -12.98% | -3.40% | 47.39% | 63.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.91% | -12.98% | -3.40% | 47.39% | 63.72% |
| EBIT | 31.60% | -13.91% | 45.48% | 47.87% | 63.81% |
| EBITDA | 6.61% | -15.18% | 78.69% | 44.11% | 71.03% |
| EPS Basic | 61.54% | 0.00% | -5.56% | 45.45% | 64.86% |
| Normalized Basic EPS | 50.00% | 0.00% | 45.45% | 50.00% | 65.22% |
| EPS Diluted | 61.54% | 0.00% | -5.56% | 45.45% | 64.86% |
| Normalized Diluted EPS | 50.00% | 0.00% | 45.45% | 50.00% | 65.22% |
| Average Basic Shares Outstanding | 28.26% | 16.12% | -0.06% | 1.63% | 7.15% |
| Average Diluted Shares Outstanding | 28.26% | 16.12% | -0.06% | 1.63% | 7.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |